References
- AHSAN, F., RIVAS, I. P., KHAN, M. A. and TORRES SUÁREZ, A. I., 2002, Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and micropsheres—on the phagocytosis by macrophages. Journal of Controlled Release, 79, 29–40.
- BAIN, D. F., MUNDAY, D. L. and SMITH, A., 1999, Modulation of rifampicin release from spray-dried microspheres using combinations of poly-(DL-lactide). Journal of Microencapsulation, 16, 369–385.
- Blanco-PRIErro, M.-J., BESSEGHIR, K., ZERBE, 0., ANDRIS, D., ORSOLINI, P., HEIMGARTNER, F., MERKLE, H. P. and GANDER, B., 2000, In vitro and in vivo evaluation of a somatosattin analogue released from PLGA microspheres. Journal of Controlled Release, 67, 19–28.
- DUBERNET, C., 1995, Thermoanalysis of microspheres. Thermochimica Acta, 248, 259–269. Gu, X. J. and JIANG, W., 1995, Characterisation of polymorphic forms of fluconazole using
- Fourier transform raman spectroscopy. Journal of Pharmaceutical Sciences, 84, 1438-1441.
- GUYOT, M. and FAWAZ, F., 1998, Nifedipine loaded-polymeric microspheres: preparation and physical characteristics. International Journal of Pharmaceutics, 175, 61–74.
- MITCHELL, T. G. and PERFECT, J. R., 1995, Cryptococcosis in the area of AIDS-100 years after the discovery of Cryptococcus neoformans. Clinical Microbiology Reviews, 8, 515–548.
- MOGI, T., OHTAKE, N., YOSHIDA, M., CHIMURA, R., KAMAGA, Y., ANDO, S., TSUKAMOTO, T., NAKAJIMA, T., UENODAN, H., OTSUKA, M., MATSUDA, Y., OHSHIMA, H. and MAKINO, K., 2000, Sustained release of 1713-estradiol from poly(lactide-co-glycolide) microspheres in vitro and in vivo. Colloids and Surfaces B: Biointerfaces, 17, 153–165.
- O'HARA, P. and HICKEY, A. J., 2000, Respirable PLGA microspheres for the treatment of tuberculosis: manufacture and characterization. Pharmaceutical Research, 17, 955–961.
- PRIOR, S., GAMAZO, C., IRACHE, J. M., MERKLE, H. P. and GANDER, B., 2000, Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. International Journal of Pharmaceutics, 196, 115–125.
- SAAG, M. S., GRAYBILL, R. J., LARSEN, R. A., PAPPAS, P. G., PEFECT, J. R., POWDERLY, W. G., SOBEL, J. D. and DISMUKES, W. E., 2000, Practice guidelines for the management of cryptococcal disease. Clinical Infectious Diseases, 30, 710–718.
- SANcHEz, A., VILA- JATO, J. and ALONSO, M. J., 1993, Development of biodegradable microspheres for the controlled release of cyclosporin A. International Journal of Pharmaceutics, 99, 263–273.
- SIEPMANN, J. and GOPFERICH, A., 2001, Mathematical modeling of bioerodible, polymeric drug delivery systems. Advanced Drug Delivery Reviews, 48, 229–247.
- STOLNICK, S., ILLum, L. and DAVIS, S. S., 1995, Long-circulating microparticulate drug carriers. Advanced Drug Delivery Reviews, 16, 195–214.
- TABATA, Y. and IKADA, Y., 1991, Phagocytosis of polymeric microspheres. In High Performance Biomaterials, edited by M. Szycher (Lancaster: Technomic), pp. 621–646.
- THOMASIN, C., CORRADIN, G., MEN, Y., MERKLE, H. P. and GANDER, B., 1996, Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response. Journal of Controlled Release, 41, 131–145.
- YUKSEL, N. and BAYKARA, T., 1996, Preparation and evaluation of controlled-release microspheres containing nicardipine hydrochloride. International Journal of Pharmaceutical Advances, 1, 398–407.